Your search returned 46 results.

Results
	1.	Novel approaches to therapeutic cancer vaccines. [electronic resource] by Hellstrom, Karl Erik Hellstrom, Ingegerd Producer: 20041029 In: Expert review of vaccines vol. 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	SMRP and HE4 as biomarkers for ovarian carcinoma when used alone and in combination with CA125 and/or each other. [electronic resource] by Hellstrom, Ingegerd Hellstrom, Karl Erik Producer: 20080715 In: Advances in experimental medicine and biology vol. 622 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Vaccines to treat cancer--an old approach whose time has arrived. [electronic resource] by Hellstrom, Karl Erik Hellstrom, Ingegerd Producer: 20080328 In: Journal of cellular biochemistry vol. 102 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Therapeutic vaccination with tumor cells that engage CD137. [electronic resource] by Hellstrom, Karl Erik Hellstrom, Ingegerd Producer: 20031104 In: Journal of molecular medicine (Berlin, Germany) vol. 81 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma. [electronic resource] by Hellstrom, Ingegerd Hellstrom, Karl Erik Publication details: Expert opinion on medical diagnostics May 2011 In: Expert opinion on medical diagnostics vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Immune Mechanisms Are Major Players in Cancer. [electronic resource] by Hellstrom, Karl Erik Hellstrom, Ingegerd Producer: 20160615 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	From the Hellstrom paradox toward cancer cure. [electronic resource] by Hellstrom, Karl Erik Hellstrom, Ingegerd Producer: 20200403 In: Progress in molecular biology and translational science vol. 164 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Curing tumor-bearing mice by shifting a Th2 to a Th1 anti-tumor response. [electronic resource] by Hellstrom, Karl Erik Dai, Min Hellstrom, Ingegerd Producer: 20180220 In: Human antibodies vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Elafin selectively regulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis. [electronic resource] by Wei, Huafeng Hellström, Karl Erik Hellström, Ingegerd Producer: 20120730 In: Gynecologic oncology vol. 125 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Administration of cyclophosphamide changes the immune profile of tumor-bearing mice. [electronic resource] by Liu, Pu Jaffar, Jade Hellstrom, Ingegerd Hellstrom, Karl Erik Producer: 20100302 In: Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	An In Vitro Model That Predicts the Therapeutic Efficacy of Immunomodulatory Antibodies. [electronic resource] by Dai, Min Yip, Yuen Yee Hellstrom, Ingegerd Hellstrom, Karl Erik Producer: 20180104 In: Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Curing mice with large tumors by locally delivering combinations of immunomodulatory antibodies. [electronic resource] by Dai, Min Yip, Yuen Yee Hellstrom, Ingegerd Hellstrom, Karl Erik Producer: 20160318 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Dual targeting of CD137 co-stimulatory and PD-1 co-inhibitory molecules for ovarian cancer immunotherapy. [electronic resource] by Wei, Huafeng Zhao, Likun Hellstrom, Ingegerd Hellstrom, Karl Erik Guo, Yajun Publication details: Oncoimmunology In: Oncoimmunology vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Ovarian carcinomas express HE4 epitopes independently of each other. [electronic resource] by Hellstrom, Ingegerd Yip, Yuen Yee Darvas, Martin Swisher, Elizabeth Hellstrom, Karl Erik Producer: 20200625 In: Cancer treatment and research communications vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv-expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusion. [electronic resource] by Zhang, Hongtao Knutson, Keith L Hellstrom, Karl Erik Disis, Mary L Hellstrom, Ingegerd Producer: 20060310 In: Molecular cancer therapeutics vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Inhibition of TGFbeta1 makes nonimmunogenic tumor cells effective for therapeutic vaccination. [electronic resource] by Liu, Pu Jaffar, Jade Zhou, Yifeng Yang, Yi Hellström, Ingegerd Hellström, Karl Erik Producer: 20090619 In: Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Tumor Regression and Cure Depends on Sustained Th1 Responses. [electronic resource] by Dai, Min Hellstrom, Ingegerd Yip, Yuen Y Sjögren, Hans Olov Hellstrom, Karl Erik Producer: 20191001 In: Journal of immunotherapy (Hagerstown, Md. : 1997) vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Cutting edge: CD83 regulates the development of cellular immunity. [electronic resource] by Scholler, Nathalie Hayden-Ledbetter, Martha Dahlin, Amber Hellström, Ingegerd Hellström, Karl Erik Ledbetter, Jeffrey A Producer: 20020415 In: Journal of immunology (Baltimore, Md. : 1950) vol. 168 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	Gene therapy for cancer using single-chain Fv fragments specific for 4-1BB. [electronic resource] by Ye, Zhengmao Hellström, Ingegerd Hayden-Ledbetter, Martha Dahlin, Amber Ledbetter, Jeffrey A Hellström, Karl Erik Producer: 20020502 In: Nature medicine vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses. [electronic resource] by Di Paolo, Nelson C Tuve, Sebastian Ni, Shaoheng Hellström, Karl Erik Hellström, Ingegerd Lieber, André Producer: 20060214 In: Cancer research vol. 66 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 46 results.